Invention Grant
- Patent Title: Inhibitors of RAF kinases
-
Application No.: US17167599Application Date: 2021-02-04
-
Publication No.: US11667634B2Publication Date: 2023-06-06
- Inventor: Stephen W. Kaldor , Toufike Kanouni , Lee Arnold
- Applicant: Kinnate Biopharma Inc.
- Applicant Address: US CA San Diego
- Assignee: KINNATE BIOPHARMA INC.
- Current Assignee: KINNATE BIOPHARMA INC.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D519/00
Abstract:
Provided herein are heteroaryl inhibitors of receptor tyrosine kinase effector (RAF), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of disease.
Public/Granted literature
- US20210246135A1 INHIBITORS OF RAF KINASES Public/Granted day:2021-08-12
Information query
